SCHEMBL2666549

SCHEMBL2666549

CC[C@@H](COC)Oc1cc(O)cc(C(=O)NC(=N)/C=C\NC)c1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 6/20 0.38
ACACB O00763 1/20 0.32
PLAU P00749 1/20 0.31
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2666697 0.92 TDP1 (0.33) GCKPLAU
SCHEMBL13209323 0.88 GCK (0.42) GCK
SCHEMBL13209296 0.88 GCK (0.42) GCK
SCHEMBL2669305 0.85 GCK (0.32) GCK
SCHEMBL2666564 0.85 GCK (0.43) GCK
SCHEMBL13209318 0.83 GCK (0.34) GCK
SCHEMBL2666718 0.78 GCK (0.38) GCK
SCHEMBL19792903 0.76 CA12 (0.51) GCKACACB
SCHEMBL13209552 0.75 GCK (0.38) GCK
SCHEMBL13209325 0.73 GCK (0.51) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006040528-A1 PHENOXY BENZAMIDE COMPOUNDS WITH UTILITY IN THE TREATMENT OF TYPE 2 DIABETES AND OBESITY ASTRAZENECA AB (SE) 2006-04-20 WO disclosed